home / lobbying

lobbying_activities

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

238 rows where filing_period = "third_quarter", filing_year = 2013 and issue_code = "PHA" sorted by filing_year descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: filing_type, is_termination, received_date (date)

issue_code 1

  • PHA · 238 ✖

filing_year 1

  • 2013 · 238 ✖

filing_period 1

  • third_quarter · 238 ✖
id filing_uuid filing_type registrant_name registrant_id client_name filing_year ▲ filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
1437696 INJURED WORKERS PHARMACY 17cfd669-23d4-4744-8596-a049f67188ed Q3 INJURED WORKERS PHARMACY 400765309 INJURED WORKERS PHARMACY 2013 third_quarter PHA Transparency of Pharmacy Benefit Managers (bill sponsored by Rep. McMorris-Rodgers and Senator Mark Pryor); Longshoreman and Harbor Workers Amendment Act of 2011 sponsored by Senator Isakson. HOUSE OF REPRESENTATIVES,SENATE     0 0 2013-10-02T13:48:41.543000-04:00
1437726 KATE MOSS 85962f96-c422-4123-bbc4-767fb75f1d2b Q3 KATE MOSS 25988 CVS HEALTH 2013 third_quarter PHA Issues related to prescription drugabuse and drug supply chain safety. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2013-10-02T15:28:05.723000-04:00
1437742 MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY 8c49cb63-258a-4a25-ac6a-4546565120ce Q3 MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY 62277 MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY 2013 third_quarter PHA HR 1919 Safeguarding America's Pharmaceutical Act of 2013 and the Senate "track and trace" legislation HOUSE OF REPRESENTATIVES,SENATE   280000 0 0 2013-10-02T15:50:14.960000-04:00
1438047 DELAHUNT GROUP, LLC 5baf2e6c-9c65-4721-9544-66922753a6fe Q3 DELAHUNT GROUP, LLC 401066001 HEALIANCE PHARMACEUTICALS 2013 third_quarter PHA innovative diabetes treatment. HOUSE OF REPRESENTATIVES,Natl Security Agency (NSA),SENATE,State, Dept of (DOS),Treasury, Dept of 45000   0 0 2013-10-03T22:23:19.973000-04:00
1438058 AMERICAN COLLEGE OF CLINICAL PHARMACY 6ed427b5-52d2-46cd-89ad-983cceb8d0a0 Q3 AMERICAN COLLEGE OF CLINICAL PHARMACY 57258 AMERICAN COLLEGE OF CLINICAL PHARMACY 2013 third_quarter PHA Coverage for direct patient care services of qualified pharmacists under Medicare and other public health programs. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   111725 0 0 2013-10-04T09:57:27.077000-04:00
1438136 THORSEN FRENCH ADVOCACY LLC 350e721c-2f4c-4ac4-a912-c2e85544bf31 Q3 THORSEN FRENCH ADVOCACY LLC 400599826 ASTRAZENECA PHARMACEUTICALS LP 2013 third_quarter PHA Issues realted to access to pharmaceuticals. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2013-10-04T13:40:14.003000-04:00
1438310 AMERICAN COLLEGE OF EMERGENCY PHYSICIANS 35cbceef-109d-411e-a006-705685a5d3d6 Q3 AMERICAN COLLEGE OF EMERGENCY PHYSICIANS 1967 AMERICAN COLLEGE OF EMERGENCY PHYSICIANS 2013 third_quarter PHA H.R.3089 - Compounding Clarity Act H.R.3204 - Drug Quality & Security Act (Upton/Waxman) S.959 - Pharmaceutical Compounding Quality and Accountability Act S.1323 - Protecting Our Youth from Dangerous Synthetic Drugs Act of 2013 HOUSE OF REPRESENTATIVES,SENATE   609420 0 0 2013-10-07T11:17:22.010000-04:00
1438332 CYBER SECURITY RESEARCH CONSULTANTS, LLC d9368a99-7b5a-4814-8ee1-77b80b8ac6fa Q3 CYBER SECURITY RESEARCH CONSULTANTS, LLC 91694 PDFRAZER CONSULTING INC CANADIAN INTERNATIONAL PHARMACY ASSOCIATION 2013 third_quarter PHA Monitoring drug importation legislation HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2013-10-07T12:07:29.140000-04:00
1438584 UPS (UNITED PARCEL SERVICE) 12dd094d-6cba-4414-873c-2be7dc2ec610 Q3 UPS (UNITED PARCEL SERVICE) 39223 UPS (UNITED PARCEL SERVICE) 2013 third_quarter PHA - HR 1919 / S.959 Healthcare Supply Chain Safety related to Track & Trace legislation - HR 3204 Drug Quality and Security Act regarding track and trace issues Commerce, Dept of (DOC),Executive Office of the President (EOP),Federal Aviation Administration (FAA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),Office of Management & Budget (OMB),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT),Treasury, Dept of,U.S. Trade Representative (USTR),White House Office   1411126 0 0 2013-10-07T18:01:27.610000-04:00
1438811 RUBICON ADVISORS, LLC 9e17c0c2-ed8d-40d5-a2ce-2237013e0c1c Q3 RUBICON ADVISORS, LLC 315091 DYNAVAX TECHNOLOGIES 2013 third_quarter PHA Food and Drug Administration - Vaccines Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2013-10-08T11:48:20.270000-04:00
1438815 RUBICON ADVISORS, LLC d0981dd1-3944-41f4-af52-3f13754b1d88 Q3 RUBICON ADVISORS, LLC 315091 BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. 2013 third_quarter PHA Physician Payment Sunshine Act S 2029 Patent Settlements H.R. 14328 .316 Affordable Healthcare Choices Act HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2013-10-08T11:50:22.643000-04:00
1438900 CAPITOL HILL CONSULTING GROUP a96ecda9-13f9-4e5d-9dd9-c2dd55a37909 Q3 CAPITOL HILL CONSULTING GROUP 72053 PROFESSIONAL COMPOUNDING CENTERS OF AMERICA 2013 third_quarter PHA Pharmaceutical Compounding and Accountability Act (S. 959) The Compounding Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204) HOUSE OF REPRESENTATIVES,SENATE 45000   0 0 2013-10-08T13:52:15.407000-04:00
1438942 CAPITOL HILL CONSULTING GROUP a709a019-0610-480f-867a-c10a346431fc Q3 CAPITOL HILL CONSULTING GROUP 72053 ROCK & ASSOCIATES 2013 third_quarter PHA Pharmaceutical Compounding and Accountability Act (S.959) The Compounding Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204) HOUSE OF REPRESENTATIVES,SENATE 15400   0 0 2013-10-08T14:48:33.263000-04:00
1438957 CAPITOL HILL CONSULTING GROUP 3d6fc421-5520-4897-8753-a40ee26ab480 Q3 CAPITOL HILL CONSULTING GROUP 72053 WELLNESS PHARMACY 2013 third_quarter PHA Pharmaceutical Compounding and Accountability Act (S.959) The Compounding Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204) HOUSE OF REPRESENTATIVES,SENATE 6750   0 0 2013-10-08T15:03:38.857000-04:00
1438960 ROCK & ASSOCIATES 2401e3b7-3900-4465-8fbe-d8506eacb1e6 Q3 ROCK & ASSOCIATES 33545 BRAIDWOOD MANAGEMENT, INC. 2013 third_quarter PHA S.959, H.R. 3089 & H.R. 3204, legislation affecting the operation of compounding pharmacies and the availability of compounded medications. HOUSE OF REPRESENTATIVES,SENATE 11200   0 0 2013-10-08T15:05:41.507000-04:00
1438984 RUBICON ADVISORS, LLC b9ef8de1-4b1b-45b6-b86e-0848aae828bf Q3 RUBICON ADVISORS, LLC 315091 STATE MUTUAL INSURANCE COMPANY 2013 third_quarter PHA Pharmacy - Compounding HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2013-10-08T15:56:53.730000-04:00
1438985 RUBICON ADVISORS, LLC 13489f11-50fa-4bc0-8b1a-5bc14a78942b Q3 RUBICON ADVISORS, LLC 315091 TEVA PHARMACEUTICALS USA 2013 third_quarter PHA Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act HOUSE OF REPRESENTATIVES,SENATE 105000   0 0 2013-10-08T15:57:55.370000-04:00
1438999 ROCK & ASSOCIATES 407d1250-c99d-4a09-9f06-d1b3569776b2 Q3 ROCK & ASSOCIATES 33545 CAPITOL HILL CONSULTING GROUP (ON BEHALF OF WELLNESS PHARMACY) 2013 third_quarter PHA S.959, H.R. 3089 & H.R. 3204, legislation affecting the operation of compounding pharmacies and the availability of compounded medications. HOUSE OF REPRESENTATIVES,SENATE     0 0 2013-10-08T16:17:03.940000-04:00
1439020 ROCK & ASSOCIATES 2efc8e48-038e-47f8-9779-fedb2371ef54 Q3 ROCK & ASSOCIATES 33545 DIAMONDBACK DRUGS 2013 third_quarter PHA S.959, H.R. 3089 & H.R. 3204, legislation affecting the operation of compounding pharmacies and the availability of compounded medications. HOUSE OF REPRESENTATIVES,SENATE 11200   0 0 2013-10-08T16:25:12.103000-04:00
1439035 ROCK & ASSOCIATES 9128610a-95d7-427a-87ab-8fde1303fb55 Q3 ROCK & ASSOCIATES 33545 VETERINARY PHARMACIES OF AMERICA, INC. 2013 third_quarter PHA S.959, H.R. 3089 & H.R. 3204, legislation affecting the operation of compounding pharmacies and the availability of compounded medications. HOUSE OF REPRESENTATIVES,SENATE 11200   0 0 2013-10-08T16:37:20.167000-04:00
1439051 ROCK & ASSOCIATES b6a474f2-50c7-40de-b5aa-797e3d39a188 Q3 ROCK & ASSOCIATES 33545 WEDGEWOOD VILLAGE PHARMACY, INC. 2013 third_quarter PHA S.959, H.R. 3089 & H.R. 3204, legislation affecting the operation of compounding pharmacies and the availability of compounded medications. HOUSE OF REPRESENTATIVES,SENATE 11200   0 0 2013-10-08T16:47:28.187000-04:00
1439068 ROCK & ASSOCIATES 77b91e60-fecc-4557-b3a9-32df69be9c13 Q3 ROCK & ASSOCIATES 33545 WOMEN'S INTERNATIONAL PHARMACY 2013 third_quarter PHA S.959, H.R. 3089 & H.R. 3204, legislation affecting the operation of compounding pharmacies and the availability of compounded medications. HOUSE OF REPRESENTATIVES,SENATE 11200   0 0 2013-10-08T16:56:37.737000-04:00
1439210 MR. VINCENT A. PANVINI 20e44c9f-e73c-4b0a-81f1-59d0ae032565 Q3 MR. VINCENT A. PANVINI 401008845 PHRMA 2013 third_quarter PHA Medicare Part D Rebates TransPacific Partnership HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2013-10-09T10:00:43.087000-04:00
1439226 MR. VINCENT A. PANVINI b2da815a-9fdd-4068-b28a-b9a62d65b389 Q3 MR. VINCENT A. PANVINI 401008845 ELI LILLY AND COMPANY 2013 third_quarter PHA TransPacific Partnership Medicare Part D Rebates HOUSE OF REPRESENTATIVES,SENATE     0 0 2013-10-09T10:10:44.683000-04:00
1439544 HAAKE & ASSOCIATES 165dac66-79a6-4502-8f72-bd5b1ed6d454 Q3 HAAKE & ASSOCIATES 17226 JOHNSON & JOHNSON SERVICES INC. 2013 third_quarter PHA Policy and procurement matters related to vaccines Air Force, Dept of,Army, Dept of (Other),Defense, Dept of (DOD),Navy, Dept of,U.S. Coast Guard (USCG),U.S. Marines 30000   0 0 2013-10-09T14:25:39.807000-04:00
1439563 MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP) 8a00ac15-4b78-46f5-b5b5-042247a5f1d0 Q3 MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP) 24486 ASL PHARMACY HOLDING COMPANY, INC. 2013 third_quarter PHA Track compounding legislation; S.959 HOUSE OF REPRESENTATIVES,SENATE 25000   0 0 2013-10-09T14:39:48.570000-04:00
1439571 MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP) 98d696b9-4b3f-49a1-bc2a-646ded22692e Q3 MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP) 24486 ALLIED MEDICAL SUPPLY, INC. 2013 third_quarter PHA Issues affecting resellers of pharmaceutical products in HR 1919 and S. 957 HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2013-10-09T14:41:53.490000-04:00
1439576 MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP) de27842e-7a5f-48e5-af2a-7d42c610f65e Q3 MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP) 24486 DIAMONDBACK DRUGS OF DELAWARE, LLC 2013 third_quarter PHA Track compounding legislation, S.959 HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2013-10-09T14:43:56.520000-04:00
1439633 MCDERMOTT WILL & SCHULTE LLP 5ecc2361-5e02-48f3-987b-db56f256cb07 Q3 MCDERMOTT WILL & SCHULTE LLP 24338 ALLERGAN, INC. 2013 third_quarter PHA Issues related to Section 340B of the Public Health Service Act; FDA issues; health reform implementation Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2013-10-09T15:13:28.940000-04:00
1440059 PD FRAZER CONSULTING, INC. b6ca348f-0c8b-44ab-8f53-cb3beebd6237 Q3 PD FRAZER CONSULTING, INC. 65998 CANADA INTERNATIONAL PHARMACY ASSOCIATION 2013 third_quarter PHA Monitor the development of proposed bills about the importation of prescription drugs. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2013-10-10T11:35:10.250000-04:00
1440189 RUBICON ADVISORS, LLC 2e648f86-3ade-46de-91bb-f1ed35c672ee Q3 RUBICON ADVISORS, LLC 315091 ALLIANCE TO PREVENT THE ABUSE OF MEDICINES 2013 third_quarter PHA Prescription Drug Abuse Police HOUSE OF REPRESENTATIVES,SENATE 52500   0 0 2013-10-10T14:02:22.970000-04:00
1440204 NATIONAL COMMUNITY PHARMACISTS ASSOCIATION 4b652acc-f909-4fd3-a612-657a49b74835 Q3 NATIONAL COMMUNITY PHARMACISTS ASSOCIATION 27478 NATIONAL COMMUNITY PHARMACISTS ASSOCIATION 2013 third_quarter PHA S. 959, Pharmaceutical Compounding Quality and Accountability Act; S. 957- Drug Supply Chain Security Act; H.R. 1919- Safeguarding America's Pharmaceuticals Act of 2013; H.R. 3089- Compounding Clarity Act of 2013; H.R. 3204 - Drug Quality and Security Act; S.867- The Medicare Prescription Drug Program Integrity and Transparency Act of 2013 Agency for Healthcare Research & Quality (AHRQ),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),Office of Personnel Management (OPM),SENATE   205000 0 0 2013-10-10T14:11:31.693000-04:00
1440213 SMITH GARSON FKA SMITH DAWSON & ANDREWS 12ab312d-b9a3-43f1-bdc5-4d4ea9f7e883 3A SMITH GARSON FKA SMITH DAWSON & ANDREWS 35707 CURE PHARMACEUTICALS 2013 third_quarter PHA Discussed federal government unpaid invoice from 2011 & 2012. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE     0 0 2013-10-10T14:15:39.453000-04:00
1440602 LNE GROUP d1f205c0-a221-4dff-993c-424c18d99fcf Q3 LNE GROUP 308811 INTRINSIQ MATERIALS 2013 third_quarter PHA Lobbied on pharmacy issues HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2013-10-11T09:52:23.303000-04:00
1440688 ACADEMY OF MANAGED CARE PHARMACY 2388cc5c-6ce0-41ef-8c38-c752b9165c66 Q3 ACADEMY OF MANAGED CARE PHARMACY 48793 ACADEMY OF MANAGED CARE PHARMACY 2013 third_quarter PHA S 959 - legislation would define a compounding manufacturer and a traditional compounder and provide limitations on each entity's ability to compound drugs -- HR 2186 requires registration of manufacturers that compound and requires Secretary to develop list of drugs that cannot be compounded, generally does not apply to a licensed pharmacist compounding in a state licensed pharmacy -- S 957 legislation establishes uniform national policy for the drug supply chain -- HR 1919 legislation provides enhanced securityin the drug distribution chain HOUSE OF REPRESENTATIVES,SENATE   200000 0 0 2013-10-11T10:55:03.973000-04:00
1440735 INDEPENDENT PHARMACY COOPERATIVE d4bdcaa6-9c00-46a0-ae12-88e0ad9a67de Q3 INDEPENDENT PHARMACY COOPERATIVE 313098 INDEPENDENT PHARMACY COOPERATIVE 2013 third_quarter PHA H.R. 3204 Drug Quality and Security Act (Support) HOUSE OF REPRESENTATIVES,SENATE     0 0 2013-10-11T11:15:22.110000-04:00
1440896 STANTON PARK GROUP f8d30612-a0f7-43ef-998a-4c4cfbd192aa Q3 STANTON PARK GROUP 83717 ALKERMES, INC. 2013 third_quarter PHA increasing acceptance of medication assisted therapy in treating abuse of alcohol and opioid dependence HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2013-10-11T12:46:37.847000-04:00
1441243 PARRY, ROMANI, DECONCINI & SYMMS 4d154815-348f-456c-991d-9c4f5102473a Q3 PARRY, ROMANI, DECONCINI & SYMMS 30792 POZEN, INC. 2013 third_quarter PHA Support H.R. 2985 - The Combination Drug Development Incentive Act of 2013, to provide incentives for new drug development. HOUSE OF REPRESENTATIVES,SENATE 36000   0 0 2013-10-11T16:13:50.853000-04:00
1441432 GENENTECH, INC d7be651d-323c-426d-aa92-f5e578580365 Q3 GENENTECH, INC 15920 GENENTECH INC 2013 third_quarter PHA Monitor Drug Safety and pedigree legislation. Monitor legislation and oversight on compounding pharmacies. HOUSE OF REPRESENTATIVES,SENATE   890000 0 0 2013-10-11T22:03:33.380000-04:00
1441929 GREATER NEW YORK HOSPITAL ASSOCIATION b2e141c3-6151-4a71-af7c-982a6398edd8 Q3 GREATER NEW YORK HOSPITAL ASSOCIATION 16830 GREATER NEW YORK HOSPITAL ASSOCIATION 2013 third_quarter PHA Reducing the costs of pharmaceuticals, medical devices, and supplies for consumers and health care providers, including drug shortage legislation, implementation of P.L. 112-144, medical device pricing and tax issues (including gag clauses), and preserving access to group purchasing organizations (GPOs); drug compounding bills (S.959, H.R.2090, H.R.3204); 340b HRSA guidance on the GPO exclusion (HRSA Release 2013-1); FDA mobile health guidance (FDA-2011-D-0530); andtrack and trace bills (S.957 &H.R.1919). Centers For Medicare and Medicaid Services (CMS),Federal Emergency Management Agency (FEMA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),Internal Revenue Service (IRS),SENATE,White House Office   270000 0 0 2013-10-14T14:39:55.730000-04:00
1442191 DUTKO WORLDWIDE, LLC b25dcdd6-c226-41ff-9890-b8447f1e2e7d 3T DUTKO WORLDWIDE, LLC 12868 NEWAYS INTERNATIONAL 2013 third_quarter PHA Monitor legislation pertaining to dietary supplements and pharmaceuticals, particularly the Food Safety Modernization Act (PL 111-353) and Patient Protection and Affordable Care Act (PL 111-148). Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE 20000   0 1 2013-10-14T18:34:14.537000-04:00
1442479 RED+BLUE STRATEGIES 4e31cabe-ddf4-4799-858b-430382693ea7 Q3 RED+BLUE STRATEGIES 400693064 BLUE CROSS BLUE SHIELD OF MASSACHUSETTS 2013 third_quarter PHA H.R. 3204 - The Drug Quality and Security Act as it relates to safety of medications covered by BCBSMA Issues related to opioid abuse interventions and policies to help curb fraud and abuse, while at the same time improving outcomes for individuals with pain management needs. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2013-10-15T10:44:36.800000-04:00
1442561 ROCK & ASSOCIATES b85f9265-d81d-4734-880d-b35817d2897e Q3 ROCK & ASSOCIATES 33545 US COMPOUNDING 2013 third_quarter PHA S.959, H.R. 3089 & H.R. 3204 legislation affecting the operation of compounding pharmacies and the availability of compounded medications. HOUSE OF REPRESENTATIVES,SENATE     0 0 2013-10-15T11:41:18.690000-04:00
1443039 ALZHEIMER'S FOUNDATION OF AMERICA 5b779a6b-5c9b-4a2e-a791-92fddc3ee355 Q3 ALZHEIMER'S FOUNDATION OF AMERICA 323158 ALZHEIMER'S FOUNDATION OF AMERICA 2013 third_quarter PHA CMS national coverage decision on PET imaging for AD diagnosis. Administration on Aging,Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE   26000 0 0 2013-10-15T15:43:08.910000-04:00
1443056 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. bdafac9a-fdfc-4a1a-bbaa-55e03724f9a9 Q3 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 AMERICAN SOCIETY OF HEMATOLOGY 2013 third_quarter PHA Issues related to drug shortages. Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 40000   0 0 2013-10-15T15:49:16.440000-04:00
1443072 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 3cbaa3cf-6d63-4f04-abe5-c3d678483d0e Q3 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 THE HEMOPHILIA ALLIANCE 2013 third_quarter PHA Issues related to the 340B drug discount program. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2013-10-15T15:53:24.017000-04:00
1443081 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 609c813e-19ba-4b4f-b421-67fedd99518d Q3 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 NATIONAL HEMOPHILIA FOUNDATION 2013 third_quarter PHA Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing program. HR 460 - Patients Access to Treatment Act Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE 50000   0 0 2013-10-15T15:55:30.330000-04:00
1443101 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 90066502-dc56-4fdb-a88a-79e5273adaf0 Q3 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 NATIONAL ASSOCIATION OF EPILEPSY CENTERS 2013 third_quarter PHA Issues related to anti-epileptic drugs. Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 10000   0 0 2013-10-15T15:58:41.567000-04:00
1443224 NOVO NORDISK INC. f675a849-dda3-41ab-a116-add67b24b2c1 Q3 NOVO NORDISK INC. 284790 NOVO NORDISK INC. 2013 third_quarter PHA H.R. 3204 Drug Quality and Security Act, H.R.1919 Safeguarding America's Pharmaceuticals Act of 2013 and S.959 Pharmaceutical Compounding Quality and Accountability Act (for track and trace supply chain provisions); issues regarding biosimilars; 340B Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,Veterans Affairs, Dept of (VA)   500000 0 0 2013-10-15T16:29:26.333000-04:00
1443581 UNIVERSITY OF IOWA 889ca90c-f37f-416c-bc87-65c3f45d68c2 Q3 UNIVERSITY OF IOWA 49191 UNIVERSITY OF IOWA 2013 third_quarter PHA Increased appropriations for systems to shorten the time between development of a drug and its release to the public FDA reform as it relates to drug development and research Collaborative research on drug development Human factors research related to neuropharmaceuticals Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,Transportation, Dept of (DOT)   85562 0 0 2013-10-16T10:02:14.043000-04:00
1443626 HANCE SCARBOROUGH 46fb1942-c88a-4994-ae71-69ffabd4ba27 Q3 HANCE SCARBOROUGH 17443 ALLIANCE OF INDEPENDENT PHARMACISTS - TEXAS 2013 third_quarter PHA Federal legislation affecting the practice of pharmacy and FDA regulation of compounded drugs. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2013-10-16T10:18:37.717000-04:00
1443640 HANCE SCARBOROUGH 05507985-9bb0-4946-b834-9db24eba6289 Q3 HANCE SCARBOROUGH 17443 INTRATHECAL CUSTODY ACCOUNT SUPPORTERS (INFORMAL COALITION) 2013 third_quarter PHA Monitored legislation related to physician control and patient access to intrathecal pump applications for patients with chronic pain. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2013-10-16T10:22:44.637000-04:00
1443814 340B HEALTH 8f8588a7-aad3-4d2f-94e6-4bd047459982 Q3 340B HEALTH 316434 340B HEALTH 2013 third_quarter PHA - The 340B Drug Discount program - Medicare Part B Drug Reimbursement, H.R. 2869 - Orphan Drug Rule, ACA implementation - SGR reform pay-fors Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   231546 0 0 2013-10-16T11:09:13.290000-04:00
1444006 RED+BLUE STRATEGIES 7b034c38-e0f6-4ba2-bb56-c26b2fe8e24c Q3 RED+BLUE STRATEGIES 400693064 EXPRESS SCRIPTS INC. 2013 third_quarter PHA H.R. 1367 - FEHBP Prescription Drug Integrity, Transparency and Cost Savings Act - focused on policies that would negatively impact access to mail order pharmacy Rules, regulations and guidance specific to prescription drug pricing, generic utilization and specialty pharmacy.Issues impacting PBMs in up coming health related legislation. Policies related to stopping the diversion of prescription medications in the nation's drug supply chain. Changes in International Naming policies for generic medications. ACA-related regulations impacting new rules for Exchanges specific to the promulgation of the prescription drug benefits. H.R. 3204 - The Drug Quality and Security Act. Legislation to address secure the pharmaceutical supply chain and drug compounding practices. Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2013-10-16T12:11:58.917000-04:00
1444058 THE OB-C GROUP, LLC 30652916-03fc-4102-9d61-31a4963a1982 Q3 THE OB-C GROUP, LLC 29802 ELI LILLY 2013 third_quarter PHA No specific bill number: matters relating to pharmaceutical manufacturers including Medicare Part D. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2013-10-16T12:23:25.370000-04:00
1444203 RED+BLUE STRATEGIES 51c89a96-4571-4cf0-9899-85d930296e4f Q3 RED+BLUE STRATEGIES 400693064 PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) 2013 third_quarter PHA H.R. 1367 - FEHBP Prescription Drug Integrity, Transparency and Cost Savings Act - focused on policies that would negative impact peoples access to prescription medications through mail. Issues related to the practice of giving coupons for certain prescription medications.Ongoing discussions in the Congress regarding track and trace policies to increase safety in the nation's prescription drug supply chain. CMS call letter focused on changes in policies regarding mail order and pharmacy networks. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2013-10-16T13:46:39.087000-04:00
1444219 INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP) 27135dba-a851-4565-a777-b6c3b514d5f9 Q3 INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP) 400337570 INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP) 2013 third_quarter PHA Legislation Related to Compounding Pharmacies and federal reform of the Food, Drug and Cosmetic Act related to compounding. S. 995, HR 3204 Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   187156 0 0 2013-10-16T13:54:47.117000-04:00
1444230 RED+BLUE STRATEGIES b84dbc4c-a7f0-4e19-81af-c93fcce8de24 Q3 RED+BLUE STRATEGIES 400693064 PEW CHARITABLE TRUSTS 2013 third_quarter PHA Issues related to continuing to increase the supply of new and innovative antibiotics that will help to treat the myriad antibiotic resistant strains of bugs like MRSA. H.R. 3204 - The Drug Quality and Security Act - Legislation to address the security of the nation's pharmaceutical supply chain anddrug compounding practices. H.R. 933 - Consolidation and Further Continuing Appropriations Act of 2013 - Focused on funding for the FDA, CDC and other public health related industries. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2013-10-16T13:57:52.667000-04:00
1444421 THEODOSIOU CONSULTANTS 57434c5c-5b66-49a6-bb07-e0633fb0a7b3 Q3 THEODOSIOU CONSULTANTS 54621 THEODOSIOU CONSULTANTS 2013 third_quarter PHA Pharmakentic Study Administration for Children & Families (ACF),HOUSE OF REPRESENTATIVES,SENATE     0 0 2013-10-16T14:56:01.180000-04:00
1444657 BROWN RUDNICK LLP 9711f0b4-9591-4200-996a-8b57c2afd968 3A BROWN RUDNICK LLP 287895 HOSPIRA, INC. 2013 third_quarter PHA -- Issues relating to generic drug labeling -- S. 959: The Pharmaceutical Quality, Security and Accountability Act -- H.R. 3204: The Compounding Clarity Act HOUSE OF REPRESENTATIVES,SENATE,White House Office 50000   0 0 2013-10-16T15:50:59.130000-04:00
1444968 AMERICA'S HEALTH INSURANCE PLANS, INC. (AHIP) 1704ddef-f7cf-4175-8d07-cafb4cc83bff Q3 AMERICA'S HEALTH INSURANCE PLANS, INC. (AHIP) 1581 AMERICA'S HEALTH INSURANCE PLANS INC (AHIP) 2013 third_quarter PHA H.R. 1367, FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act (Lynch) FEHBP prescription drugs16. Specific Lobbying Issues (continued): S. 214, Preserve Access to Affordable Generics Act (Klobuchar) access to generic drugs H.R. 3204, Drug Quality and Security Act (Upton) - safety of drug compounding and the security of the pharmaceutical supply chain Regulatory Issues: Issues relating to long term safety and effectiveness of medical devices and drugs, including registries; issues relating to post-market surveillance of drugs and medical devices; issues relating to access for investigational drugs; and other issues relating to health care reform implementation. Agency for Healthcare Research & Quality (AHRQ),Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Federal Bureau of Investigation (FBI),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Justice, Dept of (DOJ),Labor, Dept of (DOL),Medicare Payment Advisory Commission (MedPAC),Office of Management & Budget (OMB),Office of Personnel Management (OPM),Pension & Welfare Benefits Administration,SENATE,Treasury, Dept of,White House Office   2210000 0 0 2013-10-16T17:29:16.553000-04:00
1445060 CAPITOL HILL CONSULTING GROUP e3db9308-2373-458d-a6ac-6991d26d74ba Q3 CAPITOL HILL CONSULTING GROUP 72053 PURDUE PHARMA LLP 2013 third_quarter PHA Controlled Drug Substances Act (21 USC 13) Stop Tampering of Prescription Pills Act of 2013 (H.R. 486) HOUSE OF REPRESENTATIVES,SENATE 35000   0 0 2013-10-16T17:48:51.087000-04:00
1445167 KNIGHT CAPITOL CONSULTANTS 3b3d64e7-7e64-40cc-afcd-e78794345f22 Q3 KNIGHT CAPITOL CONSULTANTS 40036301 GENZYME CORPORATION 2013 third_quarter PHA Adequate funding for programs of the Food and Drug Administration, including implementation of the Prescription Drug User Fee Act (FY 2014 appropriations for the FDA, H.R. 2410/S. 1244/H.J. Res. 59). Assess potential impact of sequestration on public health/food and drug programs (FY 2014 appropriations for HHS, S. 1284). HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2013-10-16T19:33:34.300000-04:00
1445608 BROWN RUDNICK LLP 9b0ad315-012d-4fb3-917d-52f2157a3ba4 Q3 BROWN RUDNICK LLP 287895 HEALTHCARE DISTRIBUTION ALLIANCE F/K/A HEALTHCARE DISTRIBUTION MANAGEMENT ASSOC 2013 third_quarter PHA -- S. 621 and HR 1285: Safe Prescribing Act of 2013; -- H.R. 1919: Safeguarding America's Pharmaceuticals Act of 2013; -- H.R. 3204: The Drug Quality and Safety Act; -- S. 957: The Drug Supply Chain Security Act; -- S. 1277: Combating Prescription Drug Abuse Act HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2013-10-17T09:23:23.773000-04:00
1446015 ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS (FKA ST SHARED SERVICES LLC DBA MNK PHARMACEUTICALS) e75daeed-b95a-412c-b15c-40004f7eba20 Q3 ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS (FKA ST SHARED SERVICES LLC DBA MNK PHARMACEUTICALS) 401095056 ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS (FKA ST SHARED SERVICES LLC DBA 2013 third_quarter PHA Drug pedigree and compounding Energy, Dept of,HOUSE OF REPRESENTATIVES,SENATE   160000 0 0 2013-10-17T10:59:08.663000-04:00
1446325 THE MATHIS HARPLE GROUP cd248053-b812-4cee-b817-34ffc3c32df3 Q3 THE MATHIS HARPLE GROUP 322911 PILMA 2013 third_quarter PHA Medicare Pt D Rebates; TransPacific Partnership HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2013-10-17T11:56:22.067000-04:00
1446337 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS 197aaf38-cfac-4551-b2ea-6d7fc798a2e4 Q3 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS 3457 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS 2013 third_quarter PHA Contact concerning FDA authority to manage drug shortages and regulation of pharmacy compounding. Contact concerning HRSA oversight of 340B drug discount program. Communication with the FDA on the REMS program. Contact concerning S. 959, Pharmaceutical Compounding and Quality Accountability Act, (all sections) to address FDA oversight of certain drug compounding entities. Contact concerning HR 3204 (all sections) the Drug Quality and Security Act. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   250000 0 0 2013-10-17T11:57:25.207000-04:00
1446955 CONSUMER HEALTHCARE PRODUCTS ASSOCIATION d2a6ee41-4e40-4b98-97aa-13c8a2c74e55 Q3 CONSUMER HEALTHCARE PRODUCTS ASSOCIATION 29403 CONSUMER HEALTHCARE PRODUCTS ASSOCIATION 2013 third_quarter PHA PseudoephedrinePseudoephedrine - potential legislation to implement real-time, stop-sale electronic tracking system for sales of medications containing pseudoephedrine in order to preserve consumer access to the ingredient, common in popular cold and allergy medications (no bill number) and oppose prescription requirement (no bill number). Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Office of Natl Drug Control Policy (NDCP),SENATE   280000 0 0 2013-10-17T13:54:35.443000-04:00
1447122 EXPRESS SCRIPTS, INC. ae9dc024-53c6-4fc3-896f-a50abb43567c Q3 EXPRESS SCRIPTS, INC. 294416 EXPRESS SCRIPTS, INC. 2013 third_quarter PHA Policies related to the Federal Employees Health Benefit Program's pharmacy benefit (HR 1367); Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market (EHB, grandfathering, Rx quality, eRx, PBM disclosure requirements, MLR); regulatory implementation of a pathway for the approval of biosimilars; REMs; 340b program; policies placing restrictions on pharmacy benefit designissues regarding making prescription drugs more affordable (generic user fees; pedigree; pathway for biosimilars; REMs). General issues dealing with prescription drug abuse including Medicare Lock-in programs. General issues dealing with regulating pharmacy drug compounding. S. 867, the Medicare Prescription Drug Program Integrity and Transparency Act. Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Executive Office of the President (EOP),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Labor, Dept of (DOL),Medicare Payment Advisory Commission (MedPAC),Office of Personnel Management (OPM),SENATE,White House Office   670000 0 0 2013-10-17T14:22:53.787000-04:00
1447199 BUCHANAN INGERSOLL & ROONEY PC 5f25aeb7-6a32-4a8d-b9d1-8f7044846d72 Q3 BUCHANAN INGERSOLL & ROONEY PC 55291 GENERIC ANIMAL DRUG ALLIANCE 2013 third_quarter PHA Legislative issues relating to United States Food & Drug Administration. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2013-10-17T14:32:28.037000-04:00
1447275 BUCHANAN INGERSOLL & ROONEY PC 4329a685-94e2-450c-a78a-324429c48871 Q3 BUCHANAN INGERSOLL & ROONEY PC 55291 PENNSYLVANIA BIOTECHNOLOGY ASSOCIATION - ALA: PENNSYLVANIA BIO 2013 third_quarter PHA Life sciences, orphan drugs, medical devices, budget, PDUFA HOUSE OF REPRESENTATIVES,SENATE     0 0 2013-10-17T14:42:11.210000-04:00
1447641 MAYNARD NEXSEN PC c6f7b338-80fb-48bd-9748-9f4cf9bd4472 Q3 MAYNARD NEXSEN PC 60116 TOTAL PAIN SOLUTIONS, LLC 2013 third_quarter PHA HR 3089 - Compounding Clarity Act of 2013 Department of Defense (TriCare) = worked with Tricare on proposed prescription drug reimbursement change. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2013-10-17T15:17:00.347000-04:00
1448125 BLUECROSS BLUESHIELD OF TENNESSEE 1dbad83c-6ae4-4571-a7d8-31754f8a31a8 Q3 BLUECROSS BLUESHIELD OF TENNESSEE 6440 BLUECROSS BLUESHIELD OF TENNESSEE 2013 third_quarter PHA General Pharmacy Issues The Pharmaceutical Quality, Security, and Accountability Act S.959 HOUSE OF REPRESENTATIVES,SENATE   40000 0 0 2013-10-17T16:06:24.613000-04:00
1449013 EMPIRE CONSULTING GROUP 1abd701c-86f3-462e-a30f-1e7bdfd2b188 Q3 EMPIRE CONSULTING GROUP 400703105 PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA 2013 third_quarter PHA Issues relating to the Medicare Prescription Drug Act; issues relating to implementation of the Affordable Care Act; H.R. 1588, "Medicare Drug Savings Act of 2013"; 340 B Drug Discount Program; HR 3204, Drug Quality & Security Act HOUSE OF REPRESENTATIVES 40000   0 0 2013-10-17T18:25:45.463000-04:00
1449180 THE INGRAM GROUP LLC 5c240d4c-811d-45f7-bda4-f1a4ca20350c Q3 THE INGRAM GROUP LLC 400577737 PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) 2013 third_quarter PHA Issues related to pharmaceutical importation, issues related to generic drugs, and S.CON.RES.8, An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2014, revising the appropriate budgetary levels for fiscal year 2013, and setting forth the appropriate budgetary levels for fiscal years 2015 through 2023. Issues related to the Drug Supply Chain Security Act of 2013 S.957. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2013-10-17T21:24:59.617000-04:00
1449756 HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) ee1c2c7b-8dd6-4b1e-b3b2-cc2bc7136805 Q3 HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) 28776 HEALTHCARE DISTRIBUTION ALLIANCE (FORMERLY - HDMA) 2013 third_quarter PHA Rx Pedigree (S. 959, S. 957, H.R. 1919) (H.R. 2186) (H.R. 3204); Prescription Drug Monitoring Programs; Drug Abuse (S. 348), Hydrocodone Rescheduling (H.R. 1285, S. 621); Dextromethorphan (S. 644), Prescription Drug Abuse (S. 1277); Drug Shortages - Gray Market (H.R. 1958); Counterfeit Drugs; Importation of Prescription Drugs Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   285000 0 0 2013-10-18T09:48:00.877000-04:00
1449809 SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 0636918b-f317-4c69-ab36-a279d1ef8a38 Q3 SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 35968 SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 2013 third_quarter PHA Pharmacy compounding of radiopharmaceuticals; The Drug Quality and Security Act (H.R. 3204). Centers For Medicare and Medicaid Services (CMS),Energy, Dept of,Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE   80000 0 0 2013-10-18T10:00:17.547000-04:00
1450398 AMERICAN ASSOCIATION OF NURSE PRACTITIONERS 434d2e97-368f-494c-a67e-f371a0d2f7cd Q3 AMERICAN ASSOCIATION OF NURSE PRACTITIONERS 401040928 AMERICAN ASSOCIATION OF NURSE PRACTITIONERS 2013 third_quarter PHA Legislation and policies relating to: FDA Drug Safety and Risk Management Advisory Committee January 25 recommendation to reschedule hydrocodone as a Schedule II controlled substance H.R. 1285 - To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drugH.R. 1919 - Safeguarding America's Pharmaceuticals Act S. 621 Safe Prescribing Act S. 959 Pharmaceutical Compounding Quality and Accountability Act H.R. 3089 Compounding Clarity Act H.R. 3204 Drug Quality and Security Act Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),Office of Management & Budget (OMB),SENATE,White House Office   84089 0 0 2013-10-18T11:25:44.733000-04:00
1450517 WHITMER & WORRALL, LLC 154e2a8c-ed8a-48ba-90be-75bc3f494465 Q3 WHITMER & WORRALL, LLC 292892 PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) 2013 third_quarter PHA Issues related to monitoring healthcare reform. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,State, Dept of (DOS) 30000   0 0 2013-10-18T11:34:32.613000-04:00
1450763 AMERICAN OPTOMETRIC ASSOCIATION 495f701b-5bc0-4fdc-82b3-34bf579c7807 Q3 AMERICAN OPTOMETRIC ASSOCIATION 2981 AMERICAN OPTOMETRIC ASSOCIATION 2013 third_quarter PHA HR 1285, To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug, all sections relating to vision. S 621, Safe Prescribing Act of 2013, all sections relating to vision. HOUSE OF REPRESENTATIVES,SENATE   280000 0 0 2013-10-18T11:54:13.927000-04:00
1451177 EVERGREEN ASSOCIATES, LTD. 4152e43a-7e49-44a2-843f-d5946007b0ad Q3 EVERGREEN ASSOCIATES, LTD. 13984 PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION 2013 third_quarter PHA - RIN: 0910-AG18, Electronic Distribution of Content Labeling for Human Prescription Drug and Biological Products - Risk Communications: Consumer Medication Information, Medication Guides, Patient Package Inserts, Professional Inserts - P.L. 112-144: Food and Drug Administration Safety and Innovation Act: Title XI- Other Provisions, Subtitle C- Miscellaneous Provisions, Sec. 1140- Study on Drug Labeling by Electronic Means- HR 1919: Safeguarding Americas Pharmaceuticals Act of 2013: Section 8- Electronic labeling - S 957: Drug Supply Chain Security Act - S 959: Pharmaceutical Compounding and Accountability Act - H.R. 3204: Drug Quality and Security Act Food & Drug Administration (FDA),Government Accountability Office (GAO),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE 10000   0 0 2013-10-18T12:28:58.580000-04:00
1451867 BLUE CROSS AND BLUE SHIELD OF FLORIDA, INC. fbdc147d-f5f6-41d5-a040-bfe860baa432 Q3 BLUE CROSS AND BLUE SHIELD OF FLORIDA, INC. 6382 BLUE CROSS AND BLUE SHIELD OF FLORIDA INC 2013 third_quarter PHA No pharmacy lobbying activity reported during the 3rd quarter. HOUSE OF REPRESENTATIVES,SENATE   490000 0 0 2013-10-18T13:30:19.063000-04:00
1451891 NATIONAL PATIENT ADVOCATE FOUNDATION 934bd007-27ce-4631-ac50-94a5c52fc59b Q3 NATIONAL PATIENT ADVOCATE FOUNDATION 28311 NATIONAL PATIENT ADVOCATE FOUNDATION 2013 third_quarter PHA Specialty Tiers Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   36807 0 0 2013-10-18T13:33:27.580000-04:00
1452129 CROSSROADS STRATEGIES, LLC 9f09fdba-6c2c-4529-93f7-2ee47a3d28a9 Q3 CROSSROADS STRATEGIES, LLC 400531586 LUMARA HEALTH 2013 third_quarter PHA S.959, Pharmaceutical Quality, Security, and Accountability Act; H.R.1919, Safeguarding America's Pharmaceuticals Act of 2013; H.R.3089, Compounding Clarity Act of 2013; FDA related issues-specifically pharmacy compounding. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2013-10-18T14:01:00.907000-04:00
1452136 ARNOLD & PORTER KAYE SCHOLER LLP ba9d7c6f-5739-48a0-b816-0213f9073cd5 Q3 ARNOLD & PORTER KAYE SCHOLER LLP 4301 INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS 2013 third_quarter PHA Issues related to the regulation of the practice of pharmacy compounding. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2013-10-18T14:03:05.843000-04:00
1452422 VORYS ADVISORS, LLC f3784435-856b-4091-ab17-d30b8fe50080 Q3 VORYS ADVISORS, LLC 400873558 AMERISOURCEBERGEN CORPORATION 2013 third_quarter PHA Various health care proposals HOUSE OF REPRESENTATIVES,SENATE     0 0 2013-10-18T14:25:01.047000-04:00
1452666 AMERICAN VETERINARY MEDICAL ASSOCIATION 08c75b06-c435-4514-8acb-e836b8937cd6 Q3 AMERICAN VETERINARY MEDICAL ASSOCIATION 3630 AMERICAN VETERINARY MEDICAL ASSOCIATION 2013 third_quarter PHA H.R. 1150 Preservation of Antibiotics for Medical Treatment Act; S. 959 Pharmaceutical Quality, Security, and Accountability Act S. 959 Pharmaceutical Quality, Security, and Accountability Act; S.622 Animal Drug and Animal Generic Drug user Fee Act H.R. 1407 Animal Drug User Fee Act; H.R. 1408 Animal Generic Drug User Fee Act; H.R. 1528/S. 1171 Veterinary Medicine Mobility Act; Fairness to Pet owners Act/Veterinary Prescription writingPHA/AGR - discussions with Congressional staff about DEA regulations impending practice of veterinary medicine; seeking passage of legislation to change underlying statute (HR 1582/S 1171) PHA - discussions with Congressional staff expressing the need for compounding of medications for use in animals PHA - inquiries to and discussions with Congressional staff and Federal Trade Commission on veterinary pet prescriptions Agriculture, Dept of (USDA),Bureau of Labor Statistics (BLS),Commerce, Dept of (DOC),Defense, Dept of (DOD),Environmental Protection Agency (EPA),Federal Trade Commission (FTC),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE   140000 0 0 2013-10-18T14:41:48.767000-04:00
1452740 THE DUBERSTEIN GROUP INC. 71f42eef-3ba5-418c-9121-6e02f5cf824e Q3 THE DUBERSTEIN GROUP INC. 12675 PFIZER INC. 2013 third_quarter PHA Pharmaceutical issues, including track and trace legislation - HR 1919, Safeguarding America's Pharmaceuticals Act of 2013; S 957, Drug Supply Chain Security Act; HR 3204, Drug Quality and Security Act. Specialty drug tiers - HR 460, Patients' Access to Treatments Act of 2013.Regulation of compounded drugs - HR 3019, S.A.F.E. Compounded Drugs Act of 2013; S 959, Pharmaceutical Quality, Security, and Accountability Act; HR 3204, Drug Quality and Security Act. HOUSE OF REPRESENTATIVES,SENATE 100000   0 0 2013-10-18T14:44:23.327000-04:00
1452748 THE DUBERSTEIN GROUP INC. 1f302404-012c-4ffd-b499-e947b0fe6794 Q3 THE DUBERSTEIN GROUP INC. 12675 PHRMA INC. 2013 third_quarter PHA Pharmaceutical issues, including Track and Trace - HR 1919, Safeguarding America's Pharmaceuticals Act of 2013; HR 3204, Drug Quality and Security Act; S 957, Drug Supply Chain Security Act. HOUSE OF REPRESENTATIVES 100000   0 0 2013-10-18T14:45:26.610000-04:00
1452845 PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION 3ed6c5b9-482e-417f-85c5-49b61853a3aa Q3 PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION 31348 PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION 2013 third_quarter PHA Provisions of PL 111-148 and PL 111-152 impacting Medicare Part D such as formulary requirements, PBM disclosure provisions, closing the Part D coverage gap Regulatory design and coverage of pharmacy benefits in health reform exchanges and the commercial market (essential health benefits, grandfathering, value-based insurance design, e-prescribing, PBM disclosure requirements, and medical loss ratio).Regulatory and proposed legislative changes to Medicare part D including pharmacy networks, classes of clinical concern, mail-service pharmacy, EGWP waivers, MTM expansion, long term care short-term fills, recovery audit contractors. Implementation of changes to the definition of Average Manufacturer Price in Medicaid Issues related to the management of Medicaid prescription drug benefits Legislation to promote generic drugs. Regulatory Implementation of the HITECH Act. FDA issues related to the Prescription Drug User Fee Act (PDUFA) (generic user fees, pedigree, REMs); implementation of approval pathway for generic biologic drugs, 340B program. Issues related to the compounding of certain drugs. S. 77, Prescription Drug and Health Improvement Act S. 557, Medication Therapy Management Empowerment Act H.R. 460, Patients Access to Treatments Act H.R. 1188, Preserving Our Hometown Independent Pharmacies Act H.R. 1367, FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act H.R. 1024, Medication Therapy Management Empowerment Act S.867, Medicare Prescription Drug Program Integrity and Transparency Act H.R. 2960, Medicare Prescription Drug Integrity Act of 2013 Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),SENATE   567911 0 0 2013-10-18T14:53:15.173000-04:00
1452881 CAPITOLOGIC LLC af5fce7e-c0d8-4156-86f0-9e63174c6881 3T CAPITOLOGIC LLC 400426045 BULALAW, LLC 2013 third_quarter PHA Federal funding of illegal prescription drug market interventions Drug Enforcement Administration (DEA),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Institute of Justice,Office of Justice Program,SENATE     0 1 2013-10-18T14:55:27.437000-04:00
1452985 THE PROCTER AND GAMBLE COMPANY 715fef79-c06e-4c1b-a60b-8d0463bf993d Q3 THE PROCTER AND GAMBLE COMPANY 32225 THE PROCTER AND GAMBLE COMPANY 2013 third_quarter PHA Dextromethorphan Abuse Reduction; Regulation of OTC drugs, devices and cosmetics; S.644, Preventing Abuse of Cough Treatments Act of 2013 Bureau of Citizenship & Immigration Services (BCIS),Commerce, Dept of (DOC),Commodity Futures Trading Commission (CFTC),Consumer Product Safety Commission (CPSC),Energy, Dept of,Environmental Protection Agency (EPA),Executive Office of the President (EOP),Federal Communications Commission (FCC),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Intl Trade Administration (ITA),Justice, Dept of (DOJ),Natl Security Council (NSC),Office of Science & Technology Policy (OSTP),Patent & Trademark Office (PTO),Securities & Exchange Commission (SEC),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT),Treasury, Dept of,U.S. Agency for International Development (USAID),U.S. Customs & Border Protection,U.S. Immigration & Customs Enforcement (ICE),U.S. International Trade Commission (ITC),U.S. Trade Representative (USTR)   759481 0 0 2013-10-18T15:03:29.533000-04:00
1453318 AMERICAN PHARMACISTS ASSOCIATION 2fd977fe-18a7-45e2-b20d-a0d0f4215db6 Q3 AMERICAN PHARMACISTS ASSOCIATION 3071 AMERICAN PHARMACISTS ASSOCIATION 2013 third_quarter PHA HCR(PL 111-152/111-148); Medicare Part D; Medication Therapy Management; Medicare Part B; reimbursement for pharmacist services; Social Security Act; DME; CMMI; transitions of care; risk evaluation and mitigation services; prescription drug monitoring program; prescription drug abuse; hydrocodone; opiods; track and trace/supply chain; ACOs; immunization; HIT; compounding; Sustainable Growth Rate; FDASIA(PL 112-144); tele-medicine; Medicare fraud, waste and abuse Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE     0 0 2013-10-18T15:20:27.280000-04:00
1453376 KAISER FOUNDATION HEALTH PLAN INC. d53a18d2-a811-42a0-9a38-bbe835395e01 Q3 KAISER FOUNDATION HEALTH PLAN INC. 21027 KAISER FOUNDATION HEALTH PLAN INC 2013 third_quarter PHA S 3187 - Food and Drug Administration Safety and Innovation Act: A bill to amend the Federal Food, Drug and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes. Sponsor: Harkin (IA) Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   110000 0 0 2013-10-18T15:22:49.187000-04:00
1453543 BROWN RUDNICK LLP 035f33ba-55f6-4c15-bf03-4aa8b2de44c1 Q3 BROWN RUDNICK LLP 287895 APOTEX CORPORATION 2013 third_quarter PHA H.R. 3204: The Drug Quality and Safety Act S. 959: The Pharmaceutical Quality, Security and Accountability Act HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2013-10-18T15:35:48.717000-04:00
1453591 BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ 873fb0a6-6d25-4428-9386-360ab06ac858 Q3 BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ 5153 AMERISOURCEBERGEN 2013 third_quarter PHA H.R. 1919/S. 957, Drug Supply Chain Security Act HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2013-10-18T15:41:07.687000-04:00
1453600 BROWN RUDNICK LLP 542d0db4-9fbb-4010-860d-490ebeca1092 Q3 BROWN RUDNICK LLP 287895 PRIME THERAPEUTICS 2013 third_quarter PHA HR 460: Patients' Access to Treatments Act of 2013 Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2013-10-18T15:43:12.483000-04:00
1454079 MASON CONSULTING, LLC 59b5d778-4c09-463a-a035-2ff51904b428 Q3 MASON CONSULTING, LLC 400660986 AMERICAN ASSOCIATION OF NURSE PRACTITIONERS 2013 third_quarter PHA Legislation and policies relating to: FDA Drug Safety and Risk Management Advisory Committee recommendation to reschedule hydrocodone as a Schedule II controlled substance H.R. 1285 - To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug H.R. 1919 - Safeguarding America's Pharmaceuticals Act S. 621 - Safe Prescribing Act S. 959 - Pharmaceutical Compounding Quality and Accountability Act H.R. 3089 - Compounding Clarity Act H.R. 3204 - Drug Quality and Security Act Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),Office of Management & Budget (OMB),SENATE,White House Office 23450   0 0 2013-10-18T16:18:40.420000-04:00
1454093 MASON CONSULTING, LLC e33148e9-301d-4d52-8d42-55eb95a01884 Q3 MASON CONSULTING, LLC 400660986 NATIONAL ASSOCIATION OF PEDIATRIC NURSE PRACTITIONERS 2013 third_quarter PHA Legislation and policies relating to: FDA Drug Safety and Risk Management Advisory Committee January 25 recommendation to reschedule hydrocodone as a Schedule II controlled substance H.R. 1285 - To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug H.R. 1919 - Safeguarding Americas Pharmaceuticals Act S. 621 - Safe Prescribing Act S. 959 - Pharmaceutical Compounding Quality and Accountability Act H.R. 3089 - Compounding Clarity Act H.R. 3204 - Drug Quality and Security Act Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),Office of Management & Budget (OMB),SENATE,White House Office 23450   0 0 2013-10-18T16:21:43.280000-04:00
1454151 FOOD MARKETPLACE INC. 303be812-5d0a-4595-bdad-0442aa55c860 Q3 FOOD MARKETPLACE INC. 15097 FOOD MARKETPLACE INC 2013 third_quarter PHA S. 644 - Preventing Abuse of Cough Treatments Act of 2013 H.R. 2835 - Restoring Access to Medication ActS.622, H.R. 1407, H.R. 1408, the Animal Drug and Animal Generic Drug User Fee Reauthorization Act of 2013 H.R.1150, S. 1256: Preservation of Antibiotics for Medical Treatment Act of 2013 H.R. 1919 Safeguarding America's Pharmaceuticals Act of 2013 S.959: Pharmaceutical Compounding Quality and Accountability Act The Compounding Clarity Act Agriculture, Dept of (USDA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),Office of Management & Budget (OMB),SENATE   125000 0 0 2013-10-18T16:26:01.217000-04:00

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE lobbying_activities (
            id INTEGER PRIMARY KEY,
            filing_uuid TEXT NOT NULL,
            filing_type TEXT NOT NULL,
            registrant_name TEXT NOT NULL,
            registrant_id INTEGER,
            client_name TEXT NOT NULL,
            filing_year INTEGER NOT NULL,
            filing_period TEXT NOT NULL,
            issue_code TEXT,
            specific_issues TEXT,
            government_entities TEXT,
            income_amount INTEGER,
            expense_amount INTEGER,
            is_no_activity INTEGER DEFAULT 0,
            is_termination INTEGER DEFAULT 0,
            received_date TEXT,
            CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
                REFERENCES lobbying_filings_raw(filing_uuid)
        );
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);
Powered by Datasette · Queries took 2005.243ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API